Thursday, October 2, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Flotek Industries Q4 2023 Financial Results Disappoint Analysts

Elaine Mendonca by Elaine Mendonca
March 12, 2024
in Breaking News
0
Energy Company Markets and money
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Flotek Industries (NYSE: FTK) released its Q4 2023 financial results on March 12, 2024. The company reported a GAAP EPS of $0.07, which was below the estimated $0.08 by 12.5%. Quarterly sales were $42.188 million, missing the estimated $47.250 million by 10.71%. This represents a 12.50% decrease in sales compared to the same period last year.

The latest earnings report from Flotek Industries paints a picture of a challenging quarter, with earnings and sales figures falling short of analyst expectations.

Flotek Industries Inc. (FTK) Stock Sees Positive Movement: Potential for Growth Ahead

On March 12, 2024, Flotek Industries Inc. (FTK) saw some positive movement in its stock performance. FTK shares experienced a price increase of $0.06 since the market last closed, representing a 2.18% rise. Additionally, in after-hours trading, the stock rose an additional $0.04. While FTK may still be trading below its 200-day moving average, the recent price movements suggest that there may be some potential for growth in the stock. Investors will want to keep an eye on how the stock performs in the coming days to see if this positive momentum continues. It’s important for investors to conduct their own research and consider their risk tolerance before making any investment decisions. Stock prices can be volatile and subject to various factors that can impact their performance. Keeping informed about the company’s financial health, industry trends, and market conditions can help investors make more informed decisions about their investments.

FTK Stock Performance Analysis: Revenue, Net Income, and EPS Trends on March 12, 2024

On March 12, 2024, FTK stock experienced mixed performances based on the financial data provided by CNN Money. The company’s total revenue for the past year was $136.09 million, showing an impressive increase of 214.53% compared to the previous year. However, the total revenue for the third quarter was $47.27 million, indicating a decrease of 6.57% since the last quarter. In terms of net income, FTK reported a net loss of $42.30 million for the past year, reflecting a decrease of 38.59% compared to the previous year. On the other hand, the net income for the third quarter was $1.29 million, showing a significant increase of 6228.57% since the last quarter. Earnings per share (EPS) for FTK also exhibited mixed results. The EPS for the past year was -$3.41, representing a decrease of 36.6% compared to the previous year. However, the EPS for the third quarter was $0.04, showing an increase of 137.18% since the last quarter. Overall, FTK stock performances on March 12, 2024, were influenced by the company’s fluctuating total revenue, net income, and earnings per share. Investors may want to closely monitor these financial indicators to assess the company’s financial health and make informed investment decisions.

Tags: FTK
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands

International General Insurance NASDAQ IGIC Reports Strong Q4 2023 Financial Results

Biotechnology Market Capitalization

CryoPort Faces Disappointing Quarterly Results but Remains Optimistic for Future Growth

Pharmaceutical Market Capitalization

Heron Therapeutics Reports Strong Financial Performance in Q4 2023

Recommended

Iridex Corporation Acquires European Patent for Groundbreaking MicroPulse Technology in Ophthalmology and Retinal Diseases

2 years ago
Tenet Healthcare Stock

Tenet Healthcare’s Rally Faces Regulatory Headwinds

2 weeks ago
Eli Lilly Stock

Eli Lilly Shares Plunge: Market Overreaction or Justified Selloff?

1 month ago

Decrease in Short Interest Indicates Bullish Sentiment Towards RPM International Inc

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD Apple BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray TSLA Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Toughbuilt Industries Shares Plummet in Catastrophic Market Collapse

Biogen’s Global Expansion and Promising Data Fuel Alzheimer’s Treatment Optimism

Is Axsome Therapeutics Positioned to Lead the Neuroscience Revolution?

UnitedHealth’s Strategic Pivot Faces Critical Test Amid Industry Pressures

Noble Corporation Completes Acquisition of Diamond Offshore Drilling

Media Giant Warner Bros. Discovery Faces Potential Acquisition Battle

Trending

aTyr Pharma Stock
Analysis

Clinical Trial Failure Sends aTyr Pharma Shares into Freefall

by Dieter Jaworski
October 2, 2025
0

aTyr Pharma's stock continues its downward spiral as disappointing clinical trial results trigger a massive selloff. The...

Workday Stock

Workday’s Strategic AI Acquisition Sparks Investor Optimism

October 2, 2025
Autodesk Stock

Autodesk Stock Positioned for AI-Driven Growth

October 2, 2025
Toughbuilt Industries Stock

Toughbuilt Industries Shares Plummet in Catastrophic Market Collapse

October 2, 2025
Biogen Stock

Biogen’s Global Expansion and Promising Data Fuel Alzheimer’s Treatment Optimism

October 2, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Clinical Trial Failure Sends aTyr Pharma Shares into Freefall
  • Workday’s Strategic AI Acquisition Sparks Investor Optimism
  • Autodesk Stock Positioned for AI-Driven Growth

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com